1.Histologic healing and clinical outcomes in ulcerative colitis
Raymond Fueng-Hin LIANG ; Huiyu LIN ; Cora Yuk-Ping CHAU ; Wee Chian LIM
Intestinal Research 2025;23(2):182-192
Background/Aims:
Growing evidence suggests histologic healing (HH) improves clinical outcomes in ulcerative colitis (UC) patients beyond endoscopic healing (EH). We hypothesize that HH is associated with better clinical outcomes in Asian UC patients, for whom data is lacking.
Methods:
We performed a retrospective study of UC patients in clinical remission (CR) with a follow-up colonoscopy and minimum 1-year follow-up post-colonoscopy. Primary outcome was clinical relapse (CRL), defined as either a Simple Clinical Colitis Activity Index score of > 2, medication escalation, hospitalization or colectomy. Predictors of CRL and HH were assessed.
Results:
One hundred patients were included with a median follow-up of 22 months. At index colonoscopy, 80 patients were in EH. On follow-up, 41 patients experienced CRL. Of 80 patients in EH, 34 (42.5%) had persistent histologic activity (Nancy Index ≥ 2) and 29 (36.3%) relapsed during the follow-up period. Amongst patients in CR and EH, those with HH had lower CRL rate (26.1% vs. 50.0%, P= 0.028) and longer CRL-free survival (mean 46.1 months vs. 31.5 months, P= 0.015) than those with persistent histologic activity. On bivariable analysis of 100 patients in CR, HH, and Mayo endoscopic score (MES) of 0 were significantly associated with lower risk of CRL. On multivariable analysis, only MES 0 remained predictive of lower CRL risk.
Conclusions
Above and beyond CR and EH, achieving HH improves clinical outcomes in Asian UC patients. However, HH may not confer incremental benefit if MES 0 has been achieved. Further prospective studies evaluating the benefit of histologically guided therapeutic decisions are needed.
2.Histologic healing and clinical outcomes in ulcerative colitis
Raymond Fueng-Hin LIANG ; Huiyu LIN ; Cora Yuk-Ping CHAU ; Wee Chian LIM
Intestinal Research 2025;23(2):182-192
Background/Aims:
Growing evidence suggests histologic healing (HH) improves clinical outcomes in ulcerative colitis (UC) patients beyond endoscopic healing (EH). We hypothesize that HH is associated with better clinical outcomes in Asian UC patients, for whom data is lacking.
Methods:
We performed a retrospective study of UC patients in clinical remission (CR) with a follow-up colonoscopy and minimum 1-year follow-up post-colonoscopy. Primary outcome was clinical relapse (CRL), defined as either a Simple Clinical Colitis Activity Index score of > 2, medication escalation, hospitalization or colectomy. Predictors of CRL and HH were assessed.
Results:
One hundred patients were included with a median follow-up of 22 months. At index colonoscopy, 80 patients were in EH. On follow-up, 41 patients experienced CRL. Of 80 patients in EH, 34 (42.5%) had persistent histologic activity (Nancy Index ≥ 2) and 29 (36.3%) relapsed during the follow-up period. Amongst patients in CR and EH, those with HH had lower CRL rate (26.1% vs. 50.0%, P= 0.028) and longer CRL-free survival (mean 46.1 months vs. 31.5 months, P= 0.015) than those with persistent histologic activity. On bivariable analysis of 100 patients in CR, HH, and Mayo endoscopic score (MES) of 0 were significantly associated with lower risk of CRL. On multivariable analysis, only MES 0 remained predictive of lower CRL risk.
Conclusions
Above and beyond CR and EH, achieving HH improves clinical outcomes in Asian UC patients. However, HH may not confer incremental benefit if MES 0 has been achieved. Further prospective studies evaluating the benefit of histologically guided therapeutic decisions are needed.
4.Digital health's impact on the patient-doctor relationship in a primary healthcare setting: A qualitative study.
Kai Ping SZE ; Yean Lyi LIM ; Qi Wei FONG ; Jacqueline Giovanna DE ROZA ; Poay Sian Sabrina LEE ; Eng Sing LEE ; Shu Yun TAN
Annals of the Academy of Medicine, Singapore 2025;54(2):129-131
5.Integrating traditional Chinese medicine into disease management in Singapore.
Hui Ping NG ; Linda Ld ZHONG ; William Wei Liang PEH ; Wai Ching LAM ; Kenneth MAK ; Shih-Hui LIM
Annals of the Academy of Medicine, Singapore 2025;54(8):491-497
INTRODUCTION:
While traditional Chinese medicine (TCM) has a long history and continues to be widely practised, its overall clinical efficacy according to conventional scientific standards remains the topic of ongoing research and exploration. This review focuses on the potential use of acupuncture and Chinese herbal medicine (CHM) in combination with Western medicine in Singapore, based on recently published data on the clinical effectiveness and cost-effectiveness of these TCM treatments.
METHOD:
We collated and summarised 71 research papers published in the past decade, focusing on randomised controlled trials, systematic reviews and population-based cohort studies that had a total sample size (treatment and control arms) exceeding 60. English-language articles published between 2015 and 2025 were identified by searching PubMed/MEDLINE, the Cochrane Library and the China National Knowledge Infrastructure. The search strategy included intervention terms like "acupuncture", "Chinese medicine", "TCM", "traditional Chinese medicine", "RCT" and "randomized controlled trial"; economic evaluation terms like "cost" and "cost-effectiveness"; and disease conditions of concern. We narrowed our research to the clinical effectiveness and cost-effectiveness of CHM in which either the individual ingredients or the products were listed as Chinese Proprietary Medicines (CPMs).
RESULTS:
The summary tables demonstrate that the integration of acupuncture and/or CPMs with conventional Western medicine can enhance treatment outcomes across various chronic and non-chronic diseases. Their affordability and preventive focus can contribute to long-term healthcare cost savings, benefiting both patients and the healthcare system as a whole.
CONCLUSION
With a robust regulatory framework, scientific validation and government support, acupunc-ture and CPMs have an important role in the management of various diseases, especially chronic ones, in Singapore.
Humans
;
Singapore
;
Medicine, Chinese Traditional/methods*
;
Acupuncture Therapy/methods*
;
Drugs, Chinese Herbal/economics*
;
Cost-Benefit Analysis
;
Disease Management
6.Singapore consensus statements on the management of obstructive sleep apnoea.
Leong Chai LEOW ; Chuen Peng LEE ; Sridhar VENKATESWARAN ; Michael Teik Chung LIM ; Oon Hoe TEOH ; Ruth CHANG ; Yam Cheng CHEE ; Khai Beng CHONG ; Ai Ping CHUA ; Joshua GOOLEY ; Hong Juan HAN ; Nur Izzianie KAMARUDDIN ; See Meng KHOO ; Lynn Huiting KOH ; Shaun Ray Han LOH ; Kok Weng LYE ; Mark IGNATIUS ; Yingjuan MOK ; Jing Hao NG ; Thun How ONG ; Chu Qin PHUA ; Rui Ya SOH ; Pei Rong SONG ; Adeline TAN ; Alvin TAN ; Terry TAN ; Jenny TANG ; David TAY ; Jade TAY ; Song Tar TOH ; Serene WONG ; Chiang Yin WONG ; Mimi YOW
Annals of the Academy of Medicine, Singapore 2025;54(10):627-643
INTRODUCTION:
Obstructive sleep apnoea (OSA) is common in Singapore, with moderate to severe OSA affecting around 30% of residents. These consensus statements aim to provide scientifically grounded recommendations for the management of OSA, standar-dise the management of OSA in Singapore and promote multidisciplinary collaboration.
METHOD:
An expert panel, which was convened in 2024, identified several areas of OSA management that require guidance. The expert panel reviewed the current literature and developed consensus statements, which were later independently voted on using a 3-point Likert scale (agree, neutral or disagree). Consensus (total ratings of agree and neutral) was set a priori at ≥80% agreement. Any statement not reaching consensus was excluded.
RESULTS:
The final consensus included 49 statements that provide guidance on the screening, diagnosis and management of adults with OSA. Additionally, 23 statements on the screening, diagnosis and management of paediatric OSA achieved consensus. These 72 consensus statements considered not only the latest clinical evidence but also the benefits and harms, resource implications, feasibility, acceptability and equity impact of the recommendations.
CONCLUSION
The statements presented in this paper aim to guide clinicians based on the most updated evidence and collective expert opinion from sleep specialists in Singapore. These recommendations should augment clinical judgement rather than replace it. Management decisions should be individualised, taking into account the patient's clinical characteristics, as well as patient and caregiver concerns and preferences.
Humans
;
Sleep Apnea, Obstructive/diagnosis*
;
Singapore
;
Consensus
;
Adult
7.Histologic healing and clinical outcomes in ulcerative colitis
Raymond Fueng-Hin LIANG ; Huiyu LIN ; Cora Yuk-Ping CHAU ; Wee Chian LIM
Intestinal Research 2025;23(2):182-192
Background/Aims:
Growing evidence suggests histologic healing (HH) improves clinical outcomes in ulcerative colitis (UC) patients beyond endoscopic healing (EH). We hypothesize that HH is associated with better clinical outcomes in Asian UC patients, for whom data is lacking.
Methods:
We performed a retrospective study of UC patients in clinical remission (CR) with a follow-up colonoscopy and minimum 1-year follow-up post-colonoscopy. Primary outcome was clinical relapse (CRL), defined as either a Simple Clinical Colitis Activity Index score of > 2, medication escalation, hospitalization or colectomy. Predictors of CRL and HH were assessed.
Results:
One hundred patients were included with a median follow-up of 22 months. At index colonoscopy, 80 patients were in EH. On follow-up, 41 patients experienced CRL. Of 80 patients in EH, 34 (42.5%) had persistent histologic activity (Nancy Index ≥ 2) and 29 (36.3%) relapsed during the follow-up period. Amongst patients in CR and EH, those with HH had lower CRL rate (26.1% vs. 50.0%, P= 0.028) and longer CRL-free survival (mean 46.1 months vs. 31.5 months, P= 0.015) than those with persistent histologic activity. On bivariable analysis of 100 patients in CR, HH, and Mayo endoscopic score (MES) of 0 were significantly associated with lower risk of CRL. On multivariable analysis, only MES 0 remained predictive of lower CRL risk.
Conclusions
Above and beyond CR and EH, achieving HH improves clinical outcomes in Asian UC patients. However, HH may not confer incremental benefit if MES 0 has been achieved. Further prospective studies evaluating the benefit of histologically guided therapeutic decisions are needed.
8.KNOWLEDGE, VIEWS, PRACTICE AND SELF-EFFICACY REGARDING COPPER INTRAUTERINE CONTRACEPTIVE DEVICE USAGE AMONG PUBLIC PRIMARY CARE DOCTORS IN SARAWAK: A CROSS-SECTIONAL STUDY
Cheong Lieng Teng ; Yik Huang Chua ; Chare Chee Kueh ; Sing Seng Lee ; Li Lian Lim ; Hie Ping Sii ; Maziah Ishak ; Chandramani Thuraisingham
Malaysian Family Physician 2025;20(1):1-6
KNOWLEDGE, VIEWS, PRACTICE AND SELF-EFFICACY REGARDING COPPER INTRAUTERINE CONTRACEPTIVE DEVICE USAGE AMONG PUBLIC PRIMARY CARE DOCTORS IN SARAWAK: A CROSS-SECTIONAL STUDY
Introduction: Intrauterine contraceptive device (IUCD) insertion is a reversible and effective way to reduce unplanned pregnancy. Doctors play a key role in IUCD usage. This study aimed to assess knowledge, views, practice and self-efficacy regarding copper IUCD usage among public primary care doctors in Sarawak.
Methods: A cross-sectional study was conducted in all public primary care clinics in Sarawak. A self-administered online survey form was distributed to doctors in the eligible clinics.
Results: A total of 312 doctors participated in the survey. Most of them (81.4%) worked in a clinic where IUCDs were available. The median knowledge score among the medical officers was 15 (maximum score: 20). The knowledge score was correlated with the length of primary care experience and was higher among the doctors who had prior IUCD training and ever had inserted IUCDs. The doctors were concerned about the side effects of IUCDs, especially perforation and pelvic inflammatory diseases, and were negatively influenced by the additional counselling time required when recommending IUCDs. They recognised IUCD usage as a long-term and reversible contraception method. Most (69.2%) doctors had inserted IUCDs before, but only 45.9% had inserted five or more IUCDs. The self-efficacy of the doctors regarding IUCD insertion was moderate (63% of the total score).
Conclusion: The knowledge and self-efficacy of the public primary care doctors in Sarawak were moderate. Although IUCDs were widely available, the number of IUCD insertions was relatively small. Further research is warranted to quantify IUCD usage and identify its barriers among nurses and patients.
9.INTENTION OF SMARTPHONE APPLICATION USAGE IN DIABETES SELF-MANAGEMENT AND ITS ASSOCIATED FACTORS AMONG PATIENTS WITH DIABETES: A CROSS-SECTIONAL STUDY
Ai Theng Cheong ; Geok Seim Lim ; Ping Yein Lee ; Siti Maisarah Mohamad Shariff
Malaysian Family Physician 2025;20(1):1-13
INTENTION OF SMARTPHONE APPLICATION USAGE IN DIABETES SELF-MANAGEMENT AND ITS ASSOCIATED FACTORS AMONG PATIENTS WITH DIABETES: A CROSS-SECTIONAL STUDY
Introduction: Many Malaysians with diabetes lack sufficient knowledge about diabetes self-management. With the widespread adoption of smartphones, mobile health (mHealth) solutions could help empower patients with diabetes to self-manage their condition effectively. This study aimed to determine the intention of patients with diabetes to use diabetes self-management applications (DSMAs) and its associated factors in a primary care setting.
Methods: A cross-sectional study was conducted at a government health clinic in the Federal Territory of Kuala Lumpur from 1 July to 30 September 2019. We recruited 723 patients with diabetes using systematic random sampling. A validated self-administered questionnaire was used to evaluate patients’ intention to use DSMAs and its associated factors were determined via multiple logistic regression.
Results: Among 719/723 patients with diabetes included in the analysis, 49.9% intended to use DSMAs. Those who had a household income of >RM 6000 (adjusted odds ratio [AOR]=10.652, 95% confidence interval [CI]=1.709–66.398, P<0.011), agreed (AOR=8.959, 95% CI=3.327–24.128, P<0.001) or neutrally agreed (AOR=3.403, 95% CI=1.188–9.749, P=0.023) with the perceived usefulness of DSMAs, did not have resistance to change (AOR=2.458, 95% CI=1.293–4.672, P=0.006) and had a facilitating condition (AOR=9.454, 95% CI=2.718–32.881, P<0.001) had higher odds of intending to use DSMAs than their counterparts.
Conclusion: Nearly half of patients with diabetes intend to use DSMAs, indicating the potential of DSMAs as alternative tools for assisting in diabetes self-management. Education focusing on the usefulness of DSMAs and exploring facilitating conditions with patients can help increase the intention of patients to use DSMAs.
10.Next-Generation Patient-Based Real-Time Quality Control Models
Xincen DUAN ; Minglong ZHANG ; Yan LIU ; Wenbo ZHENG ; Chun Yee LIM ; Sollip KIM ; Tze Ping LOH ; Wei GUO ; Rui ZHOU ; Tony BADRICK ;
Annals of Laboratory Medicine 2024;44(5):385-391
Patient-based real-time QC (PBRTQC) uses patient-derived data to assess assay performance. PBRTQC algorithms have advanced in parallel with developments in computer science and the increased availability of more powerful computers. The uptake of Artificial Intelligence in PBRTQC has been rapid, with many stated advantages over conventional approaches. However, until this review, there has been no critical comparison of these. The PBRTQC algorithms based on moving averages, regression-adjusted real-time QC, neural networks and anomaly detection are described and contrasted. As Artificial Intelligence tools become more available to laboratories, user-friendly and computationally efficient, the major disadvantages, such as complexity and the need for high computing resources, are reduced and become attractive to implement in PBRTQC applications.


Result Analysis
Print
Save
E-mail